Filing Details

Accession Number:
0001140361-15-032882
Form Type:
4
Zero Holdings:
No
Publication Time:
2015-08-19 19:41:19
Reporting Period:
2015-08-17
Filing Date:
2015-08-19
Accepted Time:
2015-08-19 19:41:19
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1416792 Relypsa Inc RLYP Pharmaceutical Preparations (2834) 260893742
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1455189 Lance Berman C/O Relypsa, Inc.
100 Cardinal Way
Redwood City CA 94063
Chief Medical Officer And Svp No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2015-08-17 710 $24.77 15,040 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
Footnotes
  1. Represents shares automatically sold pursuant to the applicable Restricted Stock Unit Award Agreement to satisfy tax withholding obligations in connection with the vesting of Restricted Stock Units ("RSUs") and delivery of shares.
  2. Includes 13,875 RSUs.